Growth Metrics

CureVac N.V (CVAC) Income from Continuing Operations: 2019-2025

Historic Income from Continuing Operations for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$68.3 million.

  • CureVac N.V's Income from Continuing Operations rose 9.27% to -$68.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $211.7 million, marking a year-over-year increase of 171.34%. This contributed to the annual value of $173.3 million for FY2024, which is 161.91% up from last year.
  • CureVac N.V's Income from Continuing Operations amounted to -$68.3 million in Q2 2025, which was down 26.83% from -$53.9 million recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Income from Continuing Operations registered a high of $318.6 billion during Q2 2021, and its lowest value of -$467.1 billion during Q4 2021.
  • Its 3-year average for Income from Continuing Operations is -$22.0 million, with a median of -$70.8 million in 2023.
  • Data for CureVac N.V's Income from Continuing Operations shows a peak YoY increase of 135,019,749.14% (in 2021) and a maximum YoY decrease of 713,346.98% (in 2021) over the last 5 years.
  • CureVac N.V's Income from Continuing Operations (Quarterly) stood at -$467.1 billion in 2021, then spiked by 99.97% to -$131.1 million in 2022, then climbed by 28.81% to -$93.3 million in 2023, then decreased by 16.53% to -$108.7 million in 2024, then grew by 9.27% to -$68.3 million in 2025.
  • Its Income from Continuing Operations was -$68.3 million in Q2 2025, compared to -$53.9 million in Q1 2025 and -$108.7 million in Q4 2024.